The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2022

Filed:

Dec. 06, 2018
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Rachel Paige Arnott, Loudonville, NY (US);

Bart E. Burgess, Glenmont, NY (US);

Michael Cupicha, Tarrytown, NY (US);

Alexei Goraltchouk, Tarrytown, NY (US);

Bryan Grygus, Cohoes, NY (US);

Mike Stelmah, Tarrytown, NY (US);

Assignee:

Regeneran Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61J 1/20 (2006.01); A61J 1/14 (2006.01); A61L 2/18 (2006.01); A61M 5/24 (2006.01); A61M 5/315 (2006.01); A61M 39/18 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61J 1/2096 (2013.01); A61J 1/1406 (2013.01); A61J 1/1443 (2013.01); A61J 1/201 (2015.05); A61J 1/2048 (2015.05); A61J 1/2072 (2015.05); A61L 2/18 (2013.01); A61M 5/2459 (2013.01); A61M 5/31511 (2013.01); A61L 2202/23 (2013.01); A61M 39/18 (2013.01); A61M 2005/247 (2013.01); A61M 2005/2474 (2013.01); A61M 2005/3118 (2013.01); A61M 2005/31518 (2013.01);
Abstract

The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.


Find Patent Forward Citations

Loading…